Osr Holdings Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.23

-0.04 (-13.46%)

As of Sep 28, 10:38 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +1,571.1% upside

Low Target $2.62

Average Target $3.76

High Target $5.13

Current Price $0.23

Current
$0.23

Target
$3.76

$2.62 $3.76 avg $5.13

Scenario Analysis

Bear Case

$2.62

1,064.4%

Low target

Base Case

$3.76

+1,571.1%

Avg target

Bull Case

$5.13

+2,180.0%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$0.91

-75.2% from high

52-Week Low

$0.08

+200.0% from low

Target vs 52W High

$3.76

+314.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%